P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Bibliographic Details
Main Authors:	L. Nastoupil, F. Morschhauser, C. W. Scholz, M. Bishton, S.-S. Yoon, P. Giri, M. C. Wei, A. Knapp, C.-C. Li, A. Bottos, H. Li, E. Purev, N. L. Bartlett
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847368.92731.fb

Internet